RHB analyst Jarick Seet has downgraded his call on medical oncology and stem cell services provider TalkMed to “hold” from his previous “buy” call.

His move comes as international medical tourists – which forms the bulk of TalkMed’s patients – takes a hit from the ongoing travel restrictions imposed to curb the spread of Covid-19 infections.

This caused a 23.2% plunge in its revenue to $14.1 million.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook